Drugs / CBI-1214
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07321106 | Jan 2026 → Apr 2029 expected | colon carcinoma | Cartography Biosciences | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBI-1214 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07321106 ↗ |
| Action | Deplete | “to mediate tumor cell killing” NCT07321106 ↗ |
| Target | LY6G6D | “binds to LY6G6D and CD3” NCT07321106 ↗ |